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Abstract
Introduction: Because of disturbed renal autoregulation, patients experiencing hypotension-induced renal insult
might need higher levels of mean arterial pressure (MAP) than the 65 mmHg recommended level in order to avoid
the progression of acute kidney insufficiency (AKI).
Methods: In 217 patients with sustained hypotension, enrolled and followed prospectively, we compared the
evolution of the mean arterial pressure (MAP) during the first 24 hours between patients who will show AKI 72
hours after inclusion (AKIh72) and patients who will not. AKIh72 was defined as the need of renal replacement
therapy or “Injury” or “Failure” classes of the 5-stage RIFLE classification (Risk, Injury, Failure, Loss of kidney function,
End-stage renal disease) for acute kidney insufficiency using the creatinine and urine output criteria. This
comparison was performed in four different subgroups of patients according to the presence or not of AKI at the
sixth hour after inclusion (AKIh6 as defined as a serum creatinine level above 1.5 times baseline value within the
first six hours) and the presence or not of septic shock at inclusion.The ability of MAP averaged over H6 to H24 to
predict AKIh72 was assessed by the area under the receiver operating characteristic curve (AUC) and compared
between groups.
Results: The MAP averaged over H6 to H24 or over H12 to H24 was significantly lower in patients who showed
AKIh72 than in those who did not, only in septic shock patients with AKIh6, whereas no link was found between
MAP and AKIh72 in the three others subgroups of patients. In patients with septic shock plus AKIh6, MAP averaged
over H6 to H24 or over H12 to H24 had an AUC of 0.83 (0.72 to 0.92) or 0.84 (0.72 to 0.92), respectively, to predict
AKIh72 . In these patients, the best level of MAP to prevent AKIh72 was between 72 and 82 mmHg.
Conclusions: MAP about 72 to 82 mmHg could be necessary to avoid acute kidney insufficiency in patients with
septic shock and initial renal function impairment.
Introduction
Acute circulatory failure is the main cause of renal fail-
ure in intensive care unit (ICU) patients [1-3], as low
cardiac output and/or low mean arterial pressure (MAP)
can cause low renal blood flow (RBF) and harm the kid-
ney [4].
Very low levels of MAP are known to increase the risk
of acute renal insufficiency (AKI) occurrence [5-7]. In
counterpart, although a MAP of at least 65 mmHg is
thought to be protective against organ failures, including
renal impairment, and is universally recommended [8],
the true value of MAP that could really protect renal
function against worsening is still unknown. In human
septic shock, two interventional prospective studies of
limited size [9,10] have shown that increasing MAP
from 65 to 75 or 85 mmHg with norepinephrine did not
result in urinary output nor serum creatinine significant
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increasing MAP from 65 to 75 mmHg resulted in an
increase in urinary output in 11 septic shock patients.
Further, a recent retrospective cohort study suggested
that levels of MAP higher than 75 mmHg could be
necessary to insure renal protection during sepsis and
septic shock [12].
In healthy conditions RBF is stable within a wide
range of MAP, due to regional autoregulation [13].
However, in shock states, and particularly in septic
shock, derangements in microcirculation and vasoreac-
tivity, although not precisely examined for human renal
perfusion, tend to increase the lowest MAP threshold
that guarantees autoregulation [14]. In addition, animal
studies have shown that in ischemic AKI, a decrease in
MAP even at high levels of MAP (above 90 mmHg)
could be responsible of a decrease in RBF, suggesting an
impairment of autoregulation in AKI [15-18]. This sug-
gests that independently of the shock state itself, shock-
induced AKI could cause the partial or total loss of the
renal autoregulation ability early in the course of the
disease [17]. This could explain the discrepancies
between the above-cited human studies [9-12] concern-
ing the relation between MAP and renal function as
they included patients regardless of the existence or not
of AKI at the time of inclusion. However, at this time,
human studies addressing the link between shock-
induced AKI and the loss of autoregulation are lacking.
We hypothesized that, due to different MAP thresholds
of renal autoregulation, patients with or without AKI at
the time of initial therapy for acute circulatory failure
could need different MAP levels to prevent the worsen-
ing of renal function or even to favour its improvement.
Accordingly, we conducted an explorative, prospective
study aimed at comparing the relation between MAP
and renal function in patients admitted for acute circu-
latory failure with different degrees of initial renal func-
tion impairment.
Materials and methods
The protocol met the criteria of a noninterventional
study design as defined by the French Law [19]. The
Ethics Committee of the Association des Réanimateurs
du Centre-Ouest, France approved the protocol and
waived informed consent. The study was conducted in
two intensive care units (ICUs) (one medical ICU in a
university hospital, one medical-surgical ICU in a regio-
nal hospital) between October 2007 and April 2009. In
both ICUs treatment of acute circulatory failure followed
national and international guidelines, especially concern-
ing septic shock. For all shock states, first line therapies
were prompt vascular volume expansion in case of prob-
able hypovolemia, immediate antibiotics in case of sepsis,
invasive mechanical ventilation if necessary, quick use of
continuous iv norepinephrine to reach a MAP level
above 65 mmHg, systematic echocardiography within the
first hours, systematic dobutamine use in case of systolic
myocardial dysfunction or low superior vena cava oxygen
saturation after volume expansion.
Patients with hypotension (defined as a systolic arterial
pressure below 90 mmHg and/or a MAP below 65
mmHg over 10 minutes) for less than 12 h were
included at the time (H1) they were carrying an arterial
line and a bladder catheter. Patients were not included
in case of renal transplant, chronic haemodialysis, dia-
betic ketoacidosis, or diabetes insipidus. Patients were
excluded if they died or were discharged before the
ninth hour after inclusion (H9), if they were started on
renal replacement therapy (RRT) before H9, or on
diuretics before H9, if the arterial and/or bladder cathe-
ters were removed before H12, or if diabetes insipidus
occurred between H1 and H72.
Data collection
We recorded age, gender, size, body weight, underlying
diseases (chronic hypertension, diabetes mellitus,
chronic cardiac failure, liver cirrhosis, chronic renal
insufficiency (defined as steady state creatinine clearance
< 60 mL/minute), presence of solitary kidney), use of
antihypertensive drugs before admission, type of antihy-
pertensive drug used (angiotensin conversion enzyme
(ACE) inhibitors; angiotensin II receptor blockers
(ARB); diuretics, calcium inhibitors), administration of
nonsteroidal anti-inflammatory drugs (NSAID), immu-
noglobulins, methotrexate, lithium, aciclovir, amphoteri-
cin, ciclosporin, tacrolimus, cisplatin, or protease
inhibitors within 72 hours before inclusion, aminoglyco-
sides or vancomycin within 96 hours before inclusion,
iodinated contrast media within five days before inclu-
sion, number of nephrotoxic drugs received before
inclusion, presence of an urinary tract obstruction or
not, urinary origin of sepsis, cause of shock (septic [20],
cardiogenic, haemorrhagic, hypovolemic), simplified
acute physiology score (SAPS II) [21], ICU and hospital
stay outcome. Recent serum creatinine at steady state
was searched for all patients in hospital electronic regis-
try and by calling the generalist practitioner. In case of
an unsuccessful search, steady state serum creatinine
was determined by the MDRD formula [22].
We also recorded the time elapsed between the begin-
ning of hypotension and inclusion, the lowest MAP
recorded before inclusion and the volume of vascular
expansion within the six hours before inclusion.
MAP and urine output, and catecholamine dosages
were recorded hourly from H1 to H72. Serum creatinine
was measured at least once between H1 and H6, at H12
and then every 12 hours duringt h eo b s e r v a t i o np e r i o d
and at ICU discharge.
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Training courses were performed in the two centres, for
physicians and ICU nurses, before the beginning of the
study, with particular attention paid to the recording of
time events (first hypotension, inclusion), to the record-
ing of hourly MAP and urine output, and to the timing
of blood sampling (for serum creatinine measurement at
H1, H6 and then every 12 hours until H72 or ICU
discharge).
Definitions and study endpoint
At H6 the patients were classified in two predefined
groups according to the creatinine criterion of the RIFLE
classification [22] taking into account the highest value of
serum creatinine between H1 and H6: 1) patients of the
“noAKI” class (noAKIh6 patients); 2) patients of the
“Risk”, “Injury” or “Failure” classes (AKI h6 patients).
The study endpoint was the presence or not of AKI at
H72. At this time patients were considered as suffering
from AKI if they were in the classes “Injury” or “Failure”
(or have been started on renal replacement therapy)
(AKI h72 patients), based on the RIFLE classification
including the creatinine and the urine output criteria.
We considered patients classified as “noAKI” or “Risk”
at H72 as not suffering from AKI at this time (noAKI
h72 patients).
Data analysis
In each patient group (noAKIh6 patients and AKIh6
patients), we compared hourly MAP at each time-point
from H6 to H24 between patients who showed AKI at
H72 and those who did not, by two-factor analysis of
variance (ANOVA) for repeated measurements. In case
of a significant link between AKI at H72 and sequential
MAP values as disclosed by ANOVA, a post hoc t-test
was used to find out time-points at which MAP was sig-
nificantly different between noAKIh72 and AKIh72
patients.
In each patients group (noAKIh6 patients and AKIh6
patients) we examined the ability of MAP averaged over
H6 to H24 and over H12 to H24 to predict AKI at H72
by calculating the area under the receiver operating
characteristic curve (AUC), determining the best thresh-
old (Youden’s method) [23], sensitivity, and specificity.
In addition to the best threshold we provide the highest
MAP threshold yielding a positive likelihood ratio (LR)
> 5 and the lowest MAP threshold yielding a negative
LR < 0.2. AUCs were compared between groups [24].
As septic shock alone represents a well-identified cause
o fA K I[ 3 ] ,w ea l s oe x a m i n e dt h ev a l u eo fM A Pt op r e -
dict AKI at H72 in the specific group of patients with
septic shock. Finally, we also searched for different rela-
tionships between MAP and AKI at H72 according to
the presence or not of chronic hypertension.
AUCs, sensitivity and specificity are given with their
95% confidence intervals (95CI). Continuous variables
are expressed as mean ± SD unless otherwise specified.
Av a l u eo fP < 0.05 was considered significant. All sta-
tistical tests were two-tailed, performed using MedCalc
®
(Mariakerke, Belgium) and Statview
® (SAS Institute,
Cary, NC, USA).
Results
Among the 256 patients enrolled, 39 met at least one
exclusion criteria (Figure 1) and 217 were analysed
(Table 1). The duration of the hourly urine output and
MAP collection period was 49 ± 19 hours. Eighteen
patients (8.3%) were started on RRT before H72 and no
other patient required RRT between H72 and ICU
discharge.
At H6, 116 patients were classified in the noAKI h6
group and 101 patients in the AKI h6 group. A total of
66 patients showed AKI at H72: 23 among the noAKIh6
patients (20%) and 43 among the AKIh6 patients (43%)
(P = 0.0004). Table 2 shows the repartition of the
patients among the different RIFLE classes at H6 and at
H72.
In 62 patients out of 217 (29%) the baseline serum
creatinine could not be retrieved and was estimated by
the MDRD formula. These patients were not different
from the patients with known baseline serum creatinine
with regard to the percentage of AKI at H6 (23 (37%) vs
78 (50%), respectively; P =0 . 1 )o ro fA K Ia tH 7 2( 1 6
(26%) vs 50 (32%), respectively; P = 0.4).
Comparison of MAP between patients groups
The two-factor ANOVA for repeated measurements
examining MAP from H6 to H24 showed that MAP was
significantly different between noAKIh72 patients and
AKIh72 patients (P = 0.016) and between noAKIh6
patients and AKIh6 patients (P =0 . 0 4 3 ) .T h ea n a l y s i s
Figure 1 Flow diagram. RRT: renal replacement therapy.
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Entire population N = 217 Patients without AKI at
H6 N = 116
Patients with AKI at
H6 N = 101
Age (years) 64 ± 15 64 ± 16 64 ± 15
Sex Male, n (%) 127 (59%) 76 (66%) 51 (50%)*
SAPSII on admission 53.2 ± 18 50.2 ± 16 56.7 ± 16*
Weight (kg) 73 ± 18 75 ± 20 71 ± 16
Size (cm) 165 ± 15 165 ± 15 165 ± 15
Underlying diseases:
hypertension, n (%) 90 (41%) 48 (41%) 42(41%)
type 1 diabetes, n (%) 2 (1.0%) 2 (2%) 0 (0%)
type 2 diabetes, n (%) 33 (15%) 15 (13%) 18 (18%)
chronic cardiac failure, n (%) 27 (12.0%) 12 (10%) 15 (15%)
liver cirrhosis, n (%) 9 (4%) 5 (4%) 4 (4%)
past history of acute renal failure, n (%) 10 (5%) 6 (5%) 4 (4%)
chronic renal failure n (%) 9 (4%) 3 (3%) 6 (6%)
Antihypertensive drugs regularly taken
ACE inhibitors, n (%) 41 (19%) 22 (20%) 19 (19%)
ARBs, n (%) 22 (10%) 12 (10%) 10 (10%)
Calcium- channels blockers, n (%) 10 (5%) 5 (4%) 5 (5%)
Diuretics, n (%) 55 (25%) 29 (25%) 26 (26%)
Nephrotoxic drugs
NSAID within 72 hours before inclusion, n (%) 9 (4%) 3 (3%) 6 (6%)
Aminoglycosids in the last 96 h, n (%) 52 (24%) 26 (22%) 26 (26%)
Vancomycin in the last 96 h, n (%) 14 (6%) 4 (3%) 10 (10%)*
Iodine containing contrast media in the last five
days, n (%)
35 (16%) 20 (17%) 15 (15%)
Cause of acute circulatory failure:
Septic shock, n (%) 127 (59%) 64 (55%) 63 (62%)
Cardiogenic shock, n (%) 18 (8%) 10 (9%) 8 (8%)
Hemorrhagic shock, n (%) 9 (4%) 4 (3%) 5 (5%)
Hypovolemic shock, n (%) 42 (20%) 27 (23%) 17 (17%)
Post cardiac arrest (%) 15 (6%) 9 (8%) 6 (6%)
Unknown n (%) 5 (2%) 3 (3%) 2 (2%)
Urinary sepsis, n (%) 26 (12%) 10 (9%) 16 (16%)
Urinary tract obstruction, n (%) 8 (4%) 3 (3%) 2 (2%)
Acute kidney insufficiency at H72, n (%) 66 (30%) 23 (20%) 43 (43%)*
ICU death, n (%) 76 (35%) 40 (34%) 36 (36%)
Hospital death, n (%) 84 (39%) 42 (36%) 42 (42%)
Time elapsed between occurrence of hypotension
and inclusion (hours)
4.1 ± 4.4
(median = 3;
IQR: 1.5 to 6.5)
4.0 ± 4.5 4.3 ± 4
Time elapsed between occurrence of hypotension
and inclusion (hours)
4.1 ± 4.4
(median = 3;
IQR: 1.5 to 6.5)
4.0 ± 4.5 4.3 ± 4
Lowest MAP before inclusion (mmHg) 52 ± 13 mm Hg (median = 53; IQR:
44 to 62)
52 ± 14 52 ± 14
MAP at inclusion (mmHg) 68 ± 16
(median = 66; IQR: 57 to 76)
67 ± 15 68 ± 17
Continuous i.v. catecholamines during the first 72
hours
Epinephrine, n (%) 2 (1%) 0 (0%) 2 (2%)
Norepinephrine alone, n (%) 107 (43.5%) 54 (43.5%) 53 (43.5%)
Dobutamine alone, n (%) 1 (4%) 0 (4%) 1 (4%)
Dobutamine + Norepinephrine, n (%) 10 (5%) 8 (5%) 2 (5%)
Epinephrine+ Norepinephrine, n (%) 7 (2%) 2 (2%) 5 (2%)
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H12 to H24 as the dependent variable, and in addition
showed a significant interaction between the factors AKI
at H6 and AKI at H72 (P = 0.049). When re-run in the
sub-group of patients with AKI at H6, with AKI at H72
and septic shock as the two independent variables, this
analysis showed that MAP from H6 to H24 was signifi-
cantly different between patients with and without AKI
at H72 (P = 0.01) and that AKI at H72 and septic shock
interacted to influence MAP (P = 0.02). These results
allowed us to compared MAP at each time point
between the different sub-groups of patients.
As illustrated in Figure 2, in the AKIh6 patients, MAP
at each time point between H10 and H24 was signifi-
cantly lower in patients who had AKI at H72 than in
those who did not. In the noAKIh6 patients, MAP did
not differ between patients who had AKI at H72 than in
those who did not. As shown in Figure 3 this difference
in MAP evolution between noAKIh72 patients and
AKIh72 patients was also retrieved in the population of
septic shock patients (n = 127) but not in patients with
non septic shock. As illustrated in Figure 4, when MAP
evolution was compared between noAKIh72 patients and
AKIh72 patients according to the presence or not of AKI
at H6 and of septic shock, it appeared that MAP from
H6 to H24 was lower in the patients who will show AKI
at H72 than in patients who will not, only in the sub-
group of patients with septic shock and AKI at H6.
Table 3 shows the AUCs for time-averaged MAP to
predict AKI at H72 in the different groups of patients. It
appears that time-averaged MAP predicted AKI at H72
with good discriminative power only in the sub-group of
patients with AKI at H6 and septic shock. In this sub-
group time-averaged MAP over H6 to H24 yielded an
AUC of 0.83 (0.72 to 0.92) associated with a sensitivity of
0.72 and specificity of 0.87. The best cut-off value of
time-averaged MAP over H6 to H24 was 72 mmHg,
which was also the highest value associated with a posi-
tive LR > 5 (5.5 (4.2 to 7.2)). The lowest value of time-
averaged MAP over H6 to H24 associated with a negative
LR < 0.2 was 80 mmHg (negative LR = 0.16 (0.04 to 0.6),
sensitivity = 0.92 (0.74 to 0.99), specificity = 0.50 (0.33 to
0.67)). In the same sub-group of patients time-averaged
M A Po v e rH 1 2t oH 2 4y i e l d e da nA U Co f0 . 8 4( 0 . 7 2t o
0.92) associated with a sensitivity of 0.78 and specificity
of 0.89. The best cut-off value of time-averaged MAP
over H12 to H24 was 72 mmHg, which was also the
highest value associated with a positive LR > 5 (6.0 (4.6
to 7.6)). The lowest value of time-averaged MAP over
H12 to H24 associated with a negative LR < 0.2 was 82
mmHg (negative LR = 0.19 (0.05 to 0.8), sensitivity =
0.92 (0.74 to 0.99), specificity = 0.50 (0.33 to 0.67)). Fig-
ure 5 shows the different AUCs of time-averaged MAP
over H6 to H24 or over H12 to H24 to predict AKI at
H72 in the four sub-groups of patients according to the
presence or not of AKI at H6 and of septic shock.
The patients who had AKI at H72 received higher
doses of vasopressors (continuous iv epinephrine and/or
norepinephrine) during the first 72 hours, a difference
especially marked during the first 24 hours as illustrated
in Figure 6. However, during the first 72 hours, 158
patients did not receive a dosage of vasopressors above
Table 1 Characteristics of the 217 patients analysed (Continued)
Epinephrine + Norepinephrine + Dobutamine, n
(%)
2 (17%) 1 (17%) 1 (17%)
None, n (%) 88 (28) 51 (28) 37 (28)
Volume expansion in the last six hours before
inclusion (mL)
2,190 ± 1,690
(median = 2,000; IQR: 1,000 to
3,000)
1,960 ± 1,720 2,460 ± 1,600*
Volume expansion from six hours before inclusion
to H72 (mL)
4,800 ± 2,660 (median = 4,500; IQR:
3,000 to 6,000)
4,450 ± 2,730 5,180 ± 2,540
ACE: Angiotensin Conversion Enzyme; AKI: Acute Kidney Insufficiency; ARB: Angiotensin II receptor blockers; IQR: interquartile range; MAP: mean arterial pressure;
NSAID: Non Steroidal Anti Inflammatory Drug.
*: Significant difference between patients with AKI at H6 and patients without AKI at H6 (P < 0.05)
Table 2 Repartition of the 217 patients among the different RIFLE classes at H6 and then at H72
RIFLE class at H6
based on creatinine criterion only (highest serum creatinine between H1 and H6)
RIFLE class at H72 based on creatinine and urine output
criteria
noAKI Risk Injury Failure or RRT
noAKI, n = 116 86 (74%) 7 (6%) 14 (12%) 9 (8%)
Risk, n = 38 18 (47%) 9 (24%) 7 (18%) 4 (11%)
Injury, n = 39 15 (38%) 5 (13%) 8 (21%) 11 (28%)
Failure, n = 24 9 (38%) 2 (8%) 3 (13%) 10 (42%)
AKI: Acute kidney insufficiency; RIFLE refers to of the 5-stage RIFLE classification (Risk, Injury, Failure, Loss of kidney function, End-stage renal disease) for acute
kidney insufficiency; RRT: Renal replacement therapy.
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these patients we considered as not receiving high doses
of vasopressors, 41 patients had AKI at H72 and among
them, 39% (16/41) had a MAP averaged over H12 to
H24 below 72 mmHg.
Discussion
The main result of this prospective study is that in
shocked patients with initial renal insult as defined by a
serum creatinine above 1.5 times the baseline value dur-
ing the first 6 hours, the occurrence of AKI during the
first 72 hours of care is linked to the time-averaged
MAP obtained with therapy during the first 24 hours. In
these patients, it appears that a MAP higher than the
universally recommended level of 65 mmHg could be
necessary to avoid worsening of renal function. Our
subgroup analyses revealed that this is especially true in
septic shock patients, whereas in patients with shock of
other origins the link between MAP and AKI at H72 is
less obvious.
MAP level is essential to protect renal function, since
below a certain MAP threshold, when autoregulation is
exceeded, RBF decreases and leads to AKI [25]. In our
study, the best threshold of time-averaged MAP over
H 6t oH 2 4o ro v e rH 1 2t oH 2 4f o rp r e d i c t i n gA K Ia t
H72, ranged from 72 to 82 mmHg in patients with AKI
Figure 2 Evolution of mean arterial pressure (MAP) during the first 24 hours. The evolution of hourly MAP (left panels) and of MAP time-
averaged MAP (right panels) compared between patients who will have acute kidney insufficiency (AKI) at H72 (black squares) and those who
will not (open squares), is shown for the whole population (top panels), for the group of patients with no AKI at H6 (middle panels) and for the
group of patients with AKI at H6 (bottom panels). The significant differences observed in MAP (from H10 to H24 for hourly MAP and from H12
to H24 for time-averaged MAP, as indicated by an asterisk upon each time point) between patients who will or will not have AKI at H72 in the
whole population (top panels) were mainly due to the patients with AKI at H6 (bottom panels). Asterisks upon time points indicate a significant
difference (P < 0.05) between patients who will have AKI at H72 (black squares) and those who will not (open squares) (post hoc comparison
after analysis of variance). Error bars represent standard errors.
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retrospective study conducted by Dunser et al. [12],
which proposed that the best MAP threshold for pre-
dicting the need of RRT in septic shock was 75 mm Hg.
Altogether, these observations suggest that patients with
septic shock and initial renal insult might need a higher
MAP than patients with lower risk of AKI. This could
be explained by the loss of autoregulation following
acute renal insult. Nevertheless, up to now clinical data
to support this view are still lacking. Only animal stu-
dies about ischemic acute renal failure induced by the
clamping of renal artery have shown an impairment of
autoregulation from the 18th hour following the renal
injury [15-18].
In our study, in the patients with non septic shock
and/or no AKI at H6, we did not determine any MAP
t h r e s h o l dt h a tc o u l dp r e d i c tA K Ia tH 7 2 .P e r h a p s
in these patients autoregulation was preserved.
Furthermore, MAP is not the sole determinant of renal
function in shock. Organ hypoperfusion and/or reperfu-
sion lead to an important inflammatory reaction and
inflammatory mediator systemic delivery known to be
involved in renal injuries [26-30]. The recent study con-
ducted by Lerolle et al. [31] confirms that renal lesions
associated with AKI in septic shock are more complex
than acute tubular injuries, involving intense capillary
leukocytic infiltration and apoptosis. Moreover, aetiology
of AKI in ICU patients is often multifactorial. The usual
AKI risk factors identified are hypertension, diabetes,
heart failure, sepsis [3,32] and a high score of illness
severity [33], all of which being not amenable to medical
intervention in the acute situation of shock. Given these
considerations, increasing MAP could be insufficient to
avoid AKI. At this time, waiting for further studies, our
results suggest that in patients with septic shock and
initial renal insult (and perhaps also in patients with
Figure 3 Mean arterial pressure (MAP) according to the presence or not of septic shock. The MAP (from H6 to H24 for hourly MAP and
for time-averaged MAP) was significantly lower in patients who will than in those who will not have AKI at H72 in the septic shock population
(as indicated by an asterisk upon each time point) (bottom panels), while no difference was found in the non septic shock patients (top panels).
Asterisks upon time points indicate a significant difference (P < 0.05) between patients who will have AKI at H72 (black squares) and those who
will not (open squares) (post hoc comparison after analysis of variance). Error bars represent standard errors.
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than the universally recommended level of 65 mmHg
could be targeted. This could be achieved with an
increase in norepinephrine dosage, as it has not been
shown to adversely affect renal perfusion [7,9,10,34,35].
Indeed the patients with low MAP are often those who
also receive the highest doses of vasopressors, and con-
sequently vasopressor dosages are statistically linked to
AKI occurrence (as illustrated in Figure 6 for our
patients). In consequence, for fear of precipitating AKI,
one might be rather timid in increasing doses of vaso-
pressors once the targeted MAP of 65 mmHg is
Figure 4 Mean arterial pressure (MAP) according to the presence of septic shock or acute kidney insufficiency. The MAP (from H6 to
H24 for hourly MAP and for time-averaged MAP) was significantly lower in patients who will than in those who will not have AKI at H72 only in
the sub-group of patients with septic shock and AKI at H6 (as indicated by an asterisk upon each time point in the bottom panels). Asterisks
upon time points indicate a significant difference (P < 0.05) between patients who will have AKI at H72 (black squares) and those who will not
(open squares) (post hoc comparison after analysis of variance). Error bars represent standard errors.
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Page 8 of 12Table 3 Discriminative power of mean arterial pressure to predict acute kidney insufficiency at H72
AUC for MAP
averaged over H6 to
H24
Best MAP
threshold
(mmHg)
Sensitivity Specificity AUC for MAP
averaged over H12 to
H24
Best MAP
threshold
(mmHg)
Sensitivity Specificity
Patients with no AKI
at H6 (n = 116)
0.53
(0.43 to 0.62)
- - - 0.50
(0.41 to 0.60)
-- -
Patients with AKI at
H6
(n = 101)
0.74*
(0.66 to 0.83)
69 0.53
(0.38 to
0.69)
0.91
(0.81 to
0.97)
0.75**
(0.66 to 0.84)
70 0.59
(0.42 to
0.74)
0.86
(0.75 to
0.94)
Patients with non
septic shock (n = 90)
0.60
(0.49 to 0.11)
- - - 0.59
(0.48 to 0.59)
-- -
Septic shock patients
(n = 127)
0.72
(0.63 to 0.79)
72 0.56
(0.38 to
0.72)
0.84
(0.74 to
0.91)
0.72
(0.63 to 0.80)
72 0.61
(0.42 to
0.77)
0.84
(0.74 to
0.91)
Non septic shock
patients only:
Patients with no AKI
at H6 (n = 52)
0.57
(0.42 to 0.71)
- - - 0.47
(0.33 to 0.61)
-- -
Patients with AKI at
H6
(n = 38)
0.59
(0.42 to 0.74)
- - - 0.61
(0.44 to 0.77)
-- -
Septic shock
patients only:
Patients with no AKI
at H6 (n = 63)
0.52
(0.39 to 0.64)
- - - 0.53
(0.40 to 0.66)
-- -
Patients with AKI at
H6
(n = 64)
0.83
†,††
(0.72 to 0.92)
72 0.72
(0.51 to
0.88)
0.87
(0.72 to
0.96)
0.84
‡,‡‡
(0.72 to 0.92)
72 0.78
(0.56 to
0.93)
0.89
(0.72-0.96)
*: P = 0.011 versus patients with no AKI at H6; **: P = 0.003 versus patients with no AKI at H6;
†: P = 0.0037 versus septic shock patients with no AKI at H6;
††: P = 0.02 versus non septic shock patients with AKI at H6;
‡: P = 0.0065 versus septic shock patients with no AKI at H6;
‡‡: P = 0.036 versus non septic shock
patients with AKI at H6
AKI: Acute kidney insufficiency; AUC: Area under the receiver operating characteristics curve; MAP: Mean arterial pressure.
Figure 5 Performance of mean arterial pressure to predict acute kidney insufficiency (AKI) at H72. The areas under the receiver operating
characteristics curves (AUC) of time-averaged MAP over H6 to H24 (left panel) and over H12 to H24 (right panel) to predict acute kidney
insufficiency (AKI) at H72 was examined in four subgroups of patients: patients with no AKI at H6 and non septic shock (black thin line), patients
with no AKI at H6 and septic shock (dashed thick line), patients with AKI at H6 and non septic shock (dashed thin line), and patients with AKI at
H6 and septic shock (black thick line). In this latter subgroup, the AUC (see values in Table 3) was significantly higher than in the three others
subgroups for time-averaged MAP over H6 to H24 (left panel) (P = 0.0037 vs the no AKI at H6 and septic shock patients; P = 0.0037 vs the no
AKI at H6 and non septic shock patients; P = 0.02 vs the AKI at H6 and non septic shock patients) and over H12 to H24 (right panel) ((P = 0.0065
vs the no AKI at H6 and septic shock patients; P = 0.002 vs the no AKI at H6 and non septic shock patients; P = 0.036 vs the AKI at H6 and non
septic shock patients). MAP: mean arterial pressure.
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Page 9 of 12attained. However, our analysis showed that a significant
number of patients with rather low MAP (< 72 mmHg)
averaged over H12 to H24 showed AKI at H72 while
not receiving vasopressors at doses extraordinarily high
(less than 0.5 μg/kg/min of epinephrine and/or norepi-
nephrine). In our opinion, there was still room for an
increase in vasopressor doses in these patients.
Current recommendations for the prevention of AKI
in the ICU [36] propose to achieve a MAP above 60 to
65 mmHg but indicate that this target pressure should
be individualized when possible, especially if knowledge
of the premorbid blood pressure is available. In case of
chronic hypertension, the autoregulation MAP thresh-
olds are known to be higher than in non hypertensive
patients, and this could suggest that higher levels of
blood pressure are necessary in hypertensive patients to
maintain RBF [37]. However, definitive clinical studies
supporting this view are difficult to retrieve in the litera-
ture. In our study population, chronic hypertension was
not a predisposing factor for AKI at H72, and we could
not identify chronic hypertension as a condition needing
higher MAP levels to avoid AKI (See Additional data
file 1). A good control of hypertension by therapeutics
before admission to the ICU could be one factor among
others explaining this apparent preservation of autore-
gulation in hypertensive patients.
Our study has several limitations. First, it is an
observational study in which the MAP level was not a
controlled variable, and as a certain degree of colinear-
i t yu n q u e s t i o n a b l ye x i s t sb e t w e e nt h es e v e r i t yo fd i s -
ease and the MAP level, this colinearity was difficult to
circumvent by our statistical analysis. However, pro-
spective studies like ours are scarce in this field and
our results add one more element to support the view
that increasing MAP above 65 mmHg might be neces-
sary at least in septic shock to prevent AKI. Second,
we did not measure cardiac output, which is an
important predictor of RBF [30], particularly in hypo-
dynamic shock. However, its role during hyperdynamic
shock is less crucial [38,39] and our population com-
prised a majority of hyperdynamic shocks like resusci-
tated septic shocks.
MAP is an important factor participating to AKI in
shock, and probably its level should be adjusted for each
individual patient, as suggested by our results and by
others studies [11,12]. Nevertheless, improvement of
macrocirculation may be insufficient to avoid shock-
induced AKI as disturbances of renal microcirculation
may persist even after restoration of optimal perfusion
pressure and cardiac output [40-42]. Evaluation of renal
perfusion with Doppler ultrasonography could help clin-
icians to improve hemodynamic management according
to renal resistive index [11,43,44].
Conclusions
We found that a threshold of MAP within 72 to 82
mmHg could be necessary to avoid AKI in septic shock
with initial renal insult. Future randomized clinical trials
are necessary to determine the MAP level to reach in
shock (septic or not). Based on our observations, con-
cerning the preservation of renal function, these trials
should focus on patients with initial renal insult.
Key messages
￿ In septic shock patients with initial renal insult, a
time-averaged mean arterial pressure between 72
a n d8 2m m H gd u r i n gt h ef i r s t2 4h o u r sw a sa s s o -
ciated with lower incidence of acute kidney insuffi-
ciency at H72.
￿ In septic shock patients with initial renal insult, a
mean arterial pressure higher than the universally
recommended level of 65 mmHg might reduce the
risk of progression or persistence of acute kidney
insufficiency.
Figure 6 Vasopressors doses administered during the first 72 hours. To draw this figure we summed the hourly doses of norepinephrine
and epinephrine (μg/kg/min.) administered continuously by iv infusion, considering these two catecholamines as equipotent in term of
vasopressor activity. It shows that the doses of vasopressor administered were higher in patients who will show acute kidney insufficiency at H72
(squares) compared to those who will not (circles), particularly during the first 24 hours, and that this difference was retrieved in septic shock
(black squares and circles) and in non septic shock patients (open squares and circles).
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Page 10 of 12Additional material
Additional file 1: The interrelationships between chronic arterial
hypertension, mean arterial pressure during shock, and the
occurrence of Acute Kidney Insufficiency. 1) Relation between chronic
hypertension and Acute Kidney Insufficiency; 2) Evolution of mean
arterial pressure during the first 24 hours compared between patients
with and without Acute Kidney Insufficiency at H72, in subgroups of
patients according to the presence or not of chronic hypertension.
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